Changes in Serum Levels of Growth Factors in Chronic Gastritis
- Authors: Matveeva L.V.1, Mosina L.M.1, Stenina M.A.2
-
Affiliations:
- National Research Ogarev Mordovia State University
- Pirogov Russian National Research Medical University
- Issue: Vol 23, No 3 (2019)
- Pages: 250-256
- Section: IMMUNOLOGY. INFECTIOUS PATHOLOGY
- URL: https://journals.rudn.ru/medicine/article/view/22513
- DOI: https://doi.org/10.22363/2313-0245-2019-23-3-250-256
Cite item
Full Text
Abstract
Chronic inflammation, contributing to atrophy of the gastric epithelium, can develop in the induction of Helicobacter pylori and other microorganisms secretion of cytokines by cells of the gastric mucosa, including growth factors. Violation of the processes of repair of the gastric mucosa in terms of immune and microbiotic imbalance is the basis of ulcer and carcinogenesis. The aim of the study was to determine the serum level and diagnostic value of growth factors in exacerbation of chronic gastritis. Materials and methods . With informed consent in 122 patients with exacerbation of chronic gastritis and 40 healthy volunteers, sampling of gastrobioptates with esophagogastroduodenoscopy (for histological and microbiological examination), 5 ml of venous blood with serum separation (for enzyme immunoassay of serum levels of growth factors) was performed. Results . The amount of granulocyte-macrophage colony stimulating factor, erythropoietin, vascular endothelial growth factor (VEGF) in the serum of patients with atrophic gastritis exceeded the values of healthy individuals, were directly related to the degree and stage of gastritis, Helicobacter pylori infection, and among themselves. The greatest diagnostic value in atrophy gastric epithelial was determined in VEGF (sensitivity - 95,9%, specificity - 48,98%, criterion more 225 pg/ml, AUC 0,654, p = 0,0072). Conclusion. Determination of serum growth factors, especially VEGF, with exacerbation of chronic gastritis is diagnostically valuable, should be used for early diagnosis of atrophy of the gastric epithelium.
About the authors
L. V. Matveeva
National Research Ogarev Mordovia State University
Author for correspondence.
Email: MatveevaLjubov1@mail.ru
SPIN-code: 6017-0118
Saransk, Russia
L. M. Mosina
National Research Ogarev Mordovia State University
Email: MatveevaLjubov1@mail.ru
SPIN-code: 2390-1111
Saransk, Russia
M. A. Stenina
Pirogov Russian National Research Medical University
Email: MatveevaLjubov1@mail.ru
SPIN-code: 3637-1959
Moscow, Russia
References
- Schlemper R.J., Riddell R.H., Kato Y., Borchard F., Cooper H.S., Dawsey S.M., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000. Vol. 47. No. 2. P. 251—255. doi: 10.1136/gut.47.2.251.
- Vladimirskaya E.B. Normal hematopoiesis and its regulation. Clinical Oncohematology. 2015. No. 8 (2). P. 109—119 (In Russ.)
- Chereshnev V.A., Gusev E.Yu. Immunological and pathophysiological mechanisms of systemic inflammation. Med. Immunol. 2012. Vol. 14. No. 1—2. P. 9—20. https://doi.org/10.15789/1563-0625-2012-1-2-9-20 (In Russ.)
- Blindar V.N., Zubrikhina G.N. Diagnostic significance of erythropoietin level determination in clinical practice (literature review). Bulletin of RONTS. N.N. Blokhin of the RAMS. 2007. Vol. 18. No. 1. P. 10—16. (In Russ.)
- Pavlov A.D., Rumyantsev A.G. Erythropoietin: new aspects and perspectives. Hematology / Oncology and immunopathology in Pediatrics. 2008. Vol. 7. No. 2. P. 5—7. (In Russ.)
- Baksheev V.I., Kolomoets N.M. Erythropoietin in clinical practice: past, present and future. Clinical medicine. 2007. No. 9. Р. 30—37. (In Russ.)
- Mangileva T.A. Erythropoietin and its effects. Tauride medical and biological Bulletin. 2014. Vol. 7. No. 3 (67). P. 111—115. (In Russ.)
- Maiese K., Chong Z.Z., Shang Y.C. Raves and risks for erythropoietin. Cytokine Growth Factor Rev. 2008. Vol. 19. P. 145—155. doi: 10.1016/j.cytogfr.2008.01.004.
- Sun L.H., Li Q., Wanq S.Q. Relationship of TCM syndrome type of gastric mucosal epithelial growth factor, vascular endothelial growth factor and proliferative cell nuclear antigen in patients with chronic atrophic gastritis. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 2008. Vol. 28 (3). P. 225—228.
- Matveeva L.V. The Role of immune dysregulation and disorders of the microbiome in the pathogenesis of precancer and cancer of the stomach [dissertation]: 14.03.09. Moscow, RUDN. 24.06.2019. 334 р. Available from: http://dissovet.rudn.ru/web-local/prep/rj/index.php?id= 47&mod=dis&dis_id=2670 (In Russ.)
- The patent RUS for the invention № 2474824. G01N 33/53. Diagnostic technique for atrophic gastritis. Matveeva L.V., Mosina L.M. Date application: 17.11.2011. Date of publication: 10.02.2013. Byul. № 4. Available from: http://www1.fips.ru/Archive/PAT/2013FULL/2013.02.10/ INDEX_RU.HTM (In Russ.)
- Khmelnitskaya K.A., Gudkova A.Ya., Shlyakhto E.V. Modern ideas about cellular and molecular mechanisms of angiogenesis. Scientific notes state medical University them. I.P. Pavlov. 2015. Vol. 22. No. 1. P. 6—13. https://doi.org/10.24884/1607-4181-2015-22-1-6-13 (In Russ.)
- Ivashkiv LB. Epigenetic regulation of macrophage polarization and function. Trends in Immunology. 2013. Vol. 34. P. 216—23. doi: 10.1016/j.it.2012.11.001